Management of Paget-Schroetter Syndrome: a Systematic Review and Meta-Analysis
European Journal of Vascular and Endovascular Surgery · 2023-12 · 66 (6) · 866-875
DOI: 10.1016/j.ejvs.2023.08.065 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2023-12. Verfasst von Frank Hoexum und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Upper Extremity Deep Vein Thrombosis. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Currently, there is no consensus on the optimal management of Paget-Schroetter syndrome (PSS). The objective was to summarise the current evidence for management of PSS with explicit attention to the clinical outcomes of different management strategies. DATA SOURCES: The Cochrane, PubMed, and Embase databases were searched for reports published between January 1990 and December 2021. REVIEW METHODS: A systematic review and meta-analysis was conducted following PRISMA 2020 guidelines. The primary endpoint was the proportion of symptom free patients at last follow up. Secondary outcomes were success of initial treatment, recurrence of thrombosis or persistent occlusion, and patency at last follow up. Meta-analyses of the primary endpoint were performed for non-comparative and comparative reports. The quality of evidence was assessed using the GRADE approach. RESULTS: Sixty reports were included (2 653 patients), with overall moderate quality. The proportions of symptom free patients in non-comparative analysis were: anticoagulation (AC), 0.54; catheter directed thrombolysis (CDT) + AC, 0.71; AC + first rib resection (FRR), 0.80; and CDT + FRR, 0.96. Pooled analysis of comparative reports confirmed the superiority of CDT + FRR compared with AC (OR 13.89, 95% CI 1.08 - 179.04; p = .040, I2 87%, very low certainty of evidence), AC + FRR (OR 2.29, 95% CI 1.21 - 4.35; p = .010, I2 0%, very low certainty of evidence), and CDT + AC (OR 8.44, 95% CI 1.12 - 59.53; p = .030, I2 63%, very low certainty of evidence). Secondary endpoints were in favour of CDT + FRR. CONCLUSION: Non-operative management of PSS with AC alone results in persistent symptoms in 46% of patients, while 96% of patients managed with CDT + FFR were symptom free at end of follow up. Superiority of CDT + FRR compared with AC, CDT + AC, and AC + FRR was confirmed by meta-analysis. The overall quality of included reports was moderate, and the level of certainty was very low.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
- General District Hospital, Aalst, Belgium.
- Department of Vascular Surgery, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, Amsterdam, the Netherlands. Electronic address: k.yeung@amsterdamumc.nl.
Zitieren
APA
Hoexum, F., Hoebink, M., Coveliers, H. M. E., Wisselink, W., Jongkind, V., & Yeung, K. K. (2023). Management of Paget-Schroetter Syndrome: a Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 66(6), 866-875. https://doi.org/10.1016/j.ejvs.2023.08.065
Vancouver
Hoexum F, Hoebink M, Coveliers HME, Wisselink W, Jongkind V, Yeung KK. Management of Paget-Schroetter Syndrome: a Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery. 2023;66(6):866-875. doi:10.1016/j.ejvs.2023.08.065
BibTeX
@article{Hoexum2023,
author = {Hoexum, Frank and Hoebink, Max and Coveliers, Hans M E and Wisselink, Willem and Jongkind, Vincent and Yeung, Kak Khee},
title = {Management of Paget-Schroetter Syndrome: a Systematic Review and Meta-Analysis},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2023},
volume = {66},
number = {6},
pages = {866--875},
doi = {10.1016/j.ejvs.2023.08.065}
}
EUVIMED